Sight Sciences, Inc.
A maker of medical devices for the eyes, Sight Sciences builds tools that treat glaucoma and dry eye disease. Its OMNI Surgical System is a minimally invasive device that lowers eye pressure without leaving an implant behind, while its TearCare System warms and clears blocked eyelid glands to relieve dry eyes. Founded in 2011 by brothers Paul and David Badawi in Menlo Park, California, the company set out to offer "interventional" alternatives to the traditional eye-drop-first approach. The name OMNI comes from the Latin for "all," reflecting that the device addresses all three known points of resistance in the eye's fluid-drainage system.
Granted 103.6K · Bought 3.49M · Sold 551.8K
Granted 1.17M · Sold 251.9K
Bought 700.0K · Sold 2.85M
Granted 611.9K · Sold 65.6K
Granted 926.2K · Sold 94.0K
Granted 855.7K · Sold 184.7K
Granted 178.1K · Bought 15.0K
Granted 512.7K · Sold 140.5K
Granted 286.3K · Sold 18.5K
Granted 291.2K · Sold 15.8K
Granted 122.9K · Sold 17.4K
Granted 103.6K
Granted 75.4K
Granted 132.8K · Bought 35.0K
Granted 103.0K
Granted 109.7K
Granted 106.8K
Granted 81.3K
Granted 11.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Encrantz StaffanDirector, 10% owner · 46 transactions | — | 7.15M | 103.6K | 3.49M | 551.8K |
| Badawi PaulPresident and CEO, Director, 10% owner · 21 transactions | — | 6.15M | 1.17M | — | 251.9K |
| HEP Partners LLC +6 co-filers10% owner, Director, 10% owner · 4 transactions | — | 5.18Mas of Jul 2022 | — | — | — |
| KCK LTD.10% owner · 1 transaction | — | 4.78Mas of Jul 2021 | — | — | — |
| D1 Capital Partners L.P. +1 co-filer10% owner · 3 transactions | — | 3.00Mas of Dec 2023 | — | 700.0K | 2.85M |
| Offer AndrewDirector · 2 transactions | — | 2.49Mas of Jul 2021 | — | — | — |
| Badawi DavidChief Technology Officer, Director · 27 transactions | — | 1.99M | 611.9K | — | 65.6K |
| Link MatthewChief Commercial Officer · 9 transactions | — | 832.3Kas of Jul 2025 | 926.2K | — | 94.0K |
| Bauerlein AlisonChief Operating Officer · 18 transactions | — | 688.9K | 855.7K | — | 184.7K |
| Selnick JesseChief Financial Officer · 7 transactions | — | 403.4Kas of Jan 2023 | 178.1K | 15.0K | — |
| Hayden Jeremy B.Chief Legal Officer · 27 transactions | — | 369.8K | 512.7K | — | 140.5K |
| Taylor BrentonEVP, Operations & R&D · 7 transactions | — | 267.8K | 286.3K | — | 18.5K |
| Park Sam BoongChief Operating Officer · 14 transactions | — | 254.8Kas of Oct 2024 | 291.2K | — | 15.8K |
| Rodberg JamesChief Financial Officer · 8 transactions | — | 230.9K | 122.9K | — | 17.4K |
| Zurbay DonaldDirector · 5 transactions | — | 193.6K | 103.6K | — | — |
| Rogers Erica J.Director · 4 transactions | — | 175.4Kas of Jun 2025 | 75.4K | — | — |
| Raheja Manohar K.EVP, Research & Development · 9 transactions | — | 167.8Kas of May 2025 | 132.8K | 35.0K | — |
| Burbach Gerhard FDirector · 2 transactions | — | 123.2K | 103.0K | — | — |
| Fountain TamaraDirector · 5 transactions | — | 109.7K | 109.7K | — | — |
| Mazzacco CatherineDirector · 5 transactions | — | 106.8K | 106.8K | — | — |
| Larsen-Becker Brenda JaneDirector · 5 transactions | — | 79.0Kas of Jun 2025 | 81.3K | — | — |
| Schroeder ValeskaDirector · 1 transaction | — | 11.9Kas of Jun 2023 | 11.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +44.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.